3rd Biological and Medicinal Chemistry Symposium for Postgraduates

Add to your list(s) Download to your calendar using vCal

• 
Dr Tony Wood (Worldwide Head of Medicinal Chemistry, Pfizer); 
Prof Malcolm Stevens (University of Nottingham); Prof Shankar Balasubramanian (University of Cambridge).
• Friday 11 December 2009, 09:00-18:00
• Wolfson Lecture Theatre, Department of Chemistry, Lensfield Road, University of Cambridge, CB2 1EW.

If you have a question about this talk, please contact Dr Rebecca Myers.

ALL WELCOME

It’s free to attend but you must register before 1 December 2009. Send completed registration form by email to Dr Rebecca Myers with “REGISTRATION BMCS SYMPOSIUM ” in the subject line. There are 3 specially invited speakers plus 9 selected students talks plus a poster session.

SESSION 1 (CHAIR) DR GORDON SAXTY , ASTEX THERAPEUTICS LTD

Welcome Prof Steven Ley University of Cambridge


Quadruplex Nucleic Acids as Functional Elements and Therapeutic Targets, Prof Shankar Balasubramanian University of Cambridge


Synthesis of Aminodiols: The Use of Transketolase and Transaminase for Stereoselective Organic Synthesis, Armando Cazares University College London

Investigation of the Effect of Small Molecules on Chromatin Modification, Annabelle Nicolas University of Cambridge

Development of 6-Substituted Purines as Selective Inhibitors of Cyclin-Dependent Kinase 2 (CDK2), Christopher Coxon Newcastle University

SESSION 2 (CHAIR) DR DOUGLAS WILLIAMSON , VERNALIS LIMITED

Chemical Whispering and the Search for Novel Antitumour Drugs Prof Malcolm Stevens School of Pharmacy, University of Nottingham

Towards Selective Anti-tuberculosis Agents, Bilal Aljaidi Strathclyde institute of Pharmacy and Biomedical Sciences

Switchable Biological Surfaces, Chun Ling Yeung School of Chemistry, University of Birmingham

Probing the ATP Binding Domain of DNA -Dependent Protein Kinase (DNA-PK) with coumarin and isocoumarin-Derived Inhibitors, Sara Payne School of Chemistry, Newcastle University

SESSION 3 (CHAIR) DR DAVE ALKER , DAVE ALKER ASSOCIATES

Chemical Biology Challenges for 21st Century Medicinal Chemistry Dr Tony Wood VP and Head of Worldwide Medicinal Chemistry, Pfizer Global R&D

Peptide Components for Synthetic Biology, Craig Armstrong University of Bristol

Activity-Based Probes Reveal a Putative S-Layer Processing Complex in C. difficile, Tam Dang Imperial College London

Towards Candidate Selection of a Novel 1,2,4,5-Tetraoxane with Antimalarial Properties Superior to the Semi-Synthetic Artemisinin Dr Richard Amewu University of Liverpool

Closing Remarks Dr Dave Alker

Followed by a wine mixer and presentation of prizes by Dr Tony Wood.

The symposium is generously sponsored by Eisai, BioFocus, Vernalis, Heptares, RSC Mid-Anglia, GSK , Astex, Takeda, Astrazeneca and Pfizer.

RSC BMCS PG Symposium Organising Committee: Dr Rebecca Myers, Dr Dave Alker, Dr Gordon Saxty (Astex)

Registration forms are available from here: “http://www-medchem.ch.cam.ac.uk/symposium08.php”

This talk is part of the BMCS Postgraduate Symposium for Biological and Medicinal Chemists series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• BMCS Postgraduate Symposium for Biological and Medicinal Chemists
• Wolfson Lecture Theatre, Department of Chemistry, Lensfield Road, University of Cambridge, CB2 1EW

Note that ex-directory lists are not shown.